Building a digital model of a cell could give researchers a way to explore biological questions through computer simulations. Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and Priscilla Chan, is bringing together technology companies and government support to pursue that goal.
Private funding backs a broader research effort
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million in Biohub. The funding is part of a $1.8 billion initiative to create AI datasets for researchers.
The aim is to give scientists digital tools to “ask, predict, and answer biological questions digitally.” In practical terms, the datasets are intended to support computer-based research into how biology works, including efforts to find new ways to prevent and manage diseases.
The investment brings together organizations with different roles: Biohub is the research nonprofit leading the effort, while the technology and AI companies are providing financial backing. The source does not describe how the investment will be divided among the three companies or specify a schedule for the dataset work.
What a virtual cell is meant to do
Founded in 2016, Biohub aims to combat diseases by creating a “virtual cell” that researchers can use for simulations. The concept is a predictive model of biology: scientists would be able to test questions digitally and use the model’s predictions to guide discovery.
That could change how some experiments begin. Instead of relying only on experiments conducted in the physical world, researchers could use a digital model to explore possible outcomes first. The source describes this as a way to accelerate scientific discovery, while leaving open how accurate or broadly useful a virtual cell will ultimately be.
Biohub’s head of science, Alex Rives, said in a press release that an accurate predictive model could let scientists perform experiments digitally. He also described creating a virtual cell as a major challenge for the next era of science, requiring coordinated data generation at national and international scale.
Government resources add data and support
The initiative also includes federal participation. The US Department of Energy will invest more than $500 million over the next five years. The National Institutes of Health will contribute datasets, repositories, and knowledge bases built from previous federal investment totalling over $500 million.
Those contributions point to the scale of the data challenge behind the project. A model intended to represent biology depends on the information available to build and inform it. Biohub’s effort therefore involves not just developing AI, but assembling and using research data from multiple sources.
The source does not specify which datasets will be included, how they will be combined, or how researchers will assess the model’s predictions. Those details matter because the stated goal depends on creating a model accurate enough to make digital experiments useful.
A research tool with ambitious aims
The initiative links AI datasets, biological simulations, and disease research in one large undertaking. Its promise rests on whether a virtual cell can help scientists ask useful questions and make reliable predictions that support work in laboratories and beyond.
For now, the announced funding and government contributions describe a commitment to build the underlying resources. The project’s eventual scientific value will depend on the quality of those resources and how effectively researchers can use them to investigate biology and disease.